Details for Patent: 10,426,782
Which drugs does patent 10,426,782 protect, and when does it expire?
Patent 10,426,782 protects OJEMDA and is included in two NDAs.
This patent has nineteen patent family members in sixteen countries.
Summary for Patent: 10,426,782
| Title: | Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation |
| Abstract: | The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen. |
| Inventor(s): | Rachael L. BRAKE, Viviana BOZON, Ching-Kuo J. CHOW, James C. DiNunzio, Katherine M. Galvin, Karuppiah Kannan, Yuki KODONO, Qunli Xu |
| Assignee: | Formulation Technologies LLC , Day One Biopharmaceuticals Inc |
| Application Number: | US15/128,714 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 10,426,782
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharms | OJEMDA | tovorafenib | FOR SUSPENSION;ORAL | 218033-001 | Apr 23, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Day One Biopharms | OJEMDA | tovorafenib | TABLET;ORAL | 217700-001 | Apr 23, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,426,782
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112016022219 | ⤷ Start Trial | |||
| Canada | 2943808 | ⤷ Start Trial | |||
| China | 106456787 | ⤷ Start Trial | |||
| Colombia | 2016003340 | ⤷ Start Trial | |||
| Costa Rica | 20160483 | ⤷ Start Trial | |||
| Dominican Republic | P2016000254 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
